The Centers for Medicare & Medicaid Services should establish a method to identify Medicare Part B
claims for compounded drugs, the Department of Health and Human Services Office of Inspector General said in report this week. OIG surveyed CMS staff and Part B Medicare Administrative Contractors to assess their oversight of Medicare claims for compounded drugs, citing public health and safety concerns following a 2012 outbreak of fungal meningitis linked to contaminated injectable compounded drugs. CMS concurred with OIG recommendations that the agency establish a...more »
claims for compounded drugs, the Department of Health and Human Services Office of Inspector General said in report this week. OIG surveyed CMS staff and Part B Medicare Administrative Contractors to assess their oversight of Medicare claims for compounded drugs, citing public health and safety concerns following a 2012 outbreak of fungal meningitis linked to contaminated injectable compounded drugs. CMS concurred with OIG recommendations that the agency establish a...more »
No comments:
Post a Comment